Skip to main content
Premium Trial:

Request an Annual Quote

Genicon Sciences, BD Biosciences Pen Microarray Collaboration

NEW YORK, Dec. 18 — Genicon Sciences is partnering with BD Biosciences Clontech to adapt its Resonance Light Scattering signal generation and detection technology for BD's microarrays.


The agreement, announced on Tuesday, gives Genicon Sciences the right to develop, manufacture, distribute, and promote its system for specific use on the BD Atlas group of microarrays. The system includes reagents, instrumentation, and analysis software.


In addition, BD Biosciences Clontech will promote Genicon's integrated assay system.


Financial details of the deal were not disclosed.


BD Biosciences Clontech, based in Palo Alto, Calif., manufactures pre-spotted glass microarrays containing up to 3,800 human, mouse, and rat DNA oligonucleotides.


Genicon Sciences, of San Diego, is a privately held company that focuses on assay technologies and development.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.